XML 39 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Cash Flows (USD $)
 9 Months Ended 12 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Dec. 31, 2012
Dec. 31, 2011
CASH FLOW FROM OPERATING ACTIVITIES:        
Net income (loss) $ (1,652,963) $ (482,530) $ 3,267 $ (1,897,606)
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities:        
Allowance for doubtful accounts   (107,000) (377,000) 386,000
Depreciation 18,351 23,026 28,603 31,462
Intangible assets 8,453 8,452 11,269 11,270
Deferred costs 11,776      
Discount on secured debt       307,932
Net discounts of notes payable and note receivable       100,000
Share-based compensation 62,272 45,054 49,842 57,180
Change in assets and liabilities:        
Accounts receivable trade 508,933 421,675 359,562 (622,253)
Due from factor 179,994 (4,749) (189,904)  
Inventory (1,494) 2,612 4,051 1,538
Prepaid expenses and other (22,644) 33,166 33,833 129,995
Accounts payable (489,453) 226,729 243,835 507,028
Accrued liabilities (181,172) 54,276 (82,234) 221,925
Deferred revenue (206,505) (156,583) (19,572) 242,418
Net cash provided by (used for) operating activities (1,764,452) 64,128 65,552 (523,111)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Proceeds from payment of note receivable       3,350,000
Capital expenditures (23,446)     (56,204)
Net cash provided by investing activities (23,446)     3,293,796
CASH FLOW FROM FINANCING ACTIVITIES:        
Issuance of common stock 1,952,693      
Repayment of notes payable     (25,000) (3,612,135)
Repayment of notes payable - related party (321,428)      
Preferred stock dividend paid       (125,209)
Proceeds from issuance of Note Payable 497,307      
Costs to issue common stock (142,133)      
Financing costs for Note Payable (57,202)      
Net cash used for financing activities 1,929,237   (25,000) (3,737,344)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 141,339 64,128 40,552 (966,659)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 83,989 43,437 43,437 1,010,096
CASH AND CASH EQUIVALENTS, END OF YEAR 225,328 107,565 83,989 43,437
Cash paid for:        
Interest 11,991     80,286
Income taxes     41,169 12,393
Issuance of warrants for deferred financing costs and equity raise $ 89,637